A comprehensive review on miR-451: A promising cancer biomarker with therapeutic potential.


Journal

Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222

Informations de publication

Date de publication:
12 2019
Historique:
received: 11 12 2018
revised: 07 05 2019
accepted: 09 05 2019
pubmed: 30 5 2019
medline: 11 6 2020
entrez: 30 5 2019
Statut: ppublish

Résumé

MicroRNAs (miRNAs) are proposed as a family of short noncoding molecules able to manage and control the expression of the gene targets at the posttranscriptional level. They contribute in several fundamental physiological mechanisms as well as a verity of human and animal diseases such as cancer progression. Among these tiny RNAs, miR-451 placed on chromosome 17 at 17q11.2 presents an essential role in many biological processes in health condition and also in pathogenesis of different diseases. Besides, it has been recently considered as a valuable biomarker for cancer detection, prognosis and treatment. Therefore, this review will provide the critical functions of miR-451 on biological mechanisms including cell cycle and proliferation, cell survival and apoptosis, differentiation and development as well as disease initiation and progression such as tumor formation, migration, invasion, and metastasis.

Identifiants

pubmed: 31140618
doi: 10.1002/jcp.28888
doi:

Substances chimiques

Biomarkers, Tumor 0
MIRN451 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

21716-21731

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Monireh Khordadmehr (M)

Department of Pathology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.

Farinaz Jigari-Asl (F)

Department of Pathology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.

Hamed Ezzati (H)

Department of Pathology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.

Roya Shahbazi (R)

Department of Pathology, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.

Sanam Sadreddini (S)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Sahar Safaei (S)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Behzad Baradaran (B)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH